VMP 11055911000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free
BNF code 0410030B0AAAAAA
Virtual Therapeutic Moiety Buprenorphine + Naloxone
Abbreviated name Buprenorphine 8mg / Naloxone 2mg sublingual tab sugar free
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Buprenorphine hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 387173000
Strength value numerator 8.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Naloxone hydrochloride dihydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372890007
Strength value numerator 2.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletsublingual.oromucosal
Dose Form
Formulation Sublingual tablet
Drug Route
Route Sublingual
Controlled Drug Prescribing Information
Controlled Drug category Schedule 3 (CD No Register)
Actual Medicinal Products
Suboxone 8mg/2mg sublingual tablets (CST Pharma Ltd)
Suboxone 8mg/2mg sublingual tablets (Indivior UK Ltd)
Virtual Medicinal Product Packs
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_6.2.0_20240617000001, imported on 17th June 2024 at 05:00:28.

Feedback